Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact
Login Book a demo
Rivaara Labs logo — Pioneering precision in diagnostics with timely, actionable...

Rivaara Labs

Pioneering precision in diagnostics with timely, actionable solutions for better healthcare outcomes.

Founded 2019 51-200 employees Private Equity Total: $600.00M Biotechnology, Health Care

General Information

Company Name Rivaara Labs
Founded Year 2019
Employees 51-200
Industries Biotechnology, Health Care
Funding Stage Private Equity
Social

BounceWatch is an independent company data service, not affiliated with Rivaara Labs. To contact Rivaara Labs, visit rivaaralabs.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Rivaara Labs compare?

A PDF of Rivaara Labs and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Rivaara Labs soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Rivaara Labs

Rivaara Labs, founded in 2019, is a biotechnology and healthcare startup focused on advancing precision diagnostics with timely, actionable solutions for improved healthcare outcomes. The company's offerings include molecular diagnostics services, clinical testing solutions, and innovative Point of Care (POC) solutions. With a strategic emphasis on building a wide network of specialized Molecular Diagnostics labs and a national reference lab, Rivaara Labs addresses the critical need for prompt, actionable information that transcends the limitations of current diagnostic and monitoring practices. The company's open, dynamic, and collaborative culture empowers teams to drive innovation in the healthcare space. In its latest funding round on 07 November 2022, Rivaara Labs secured a substantial INR600.00M investment from Kotak Investment Advisors, BHARAT V. DAFTARY, and Amicus Capital, showcasing confidence from prominent investors in the startup's vision. Rivaara Labs' commitment to bridging the gap in precision diagnostics positions it as a promising player in the biotechnology and healthcare industries, offering compelling opportunities for potential stakeholders and investors.

Business keywords: Precision Diagnostics, Molecular Diagnostics, Clinical Testing, Point of Care Solutions, Healthcare Innovation, Medical Technology, RT-PCR, NGS (Next Generation Sequencing), Pharmaceuticals, Research, Healthcare Analytics

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Private Equity Round INR600.00M 3
Kotak Investment Advisors
Kotak Investment Advisors, BHARAT V. DAFTARY +1
07 Nov 2022

Rivaara Labs Alternatives & Competitors

View All Alternatives
Rivaara Labs vs
Biocartis
Biocartis Belgium

High precision diagnostics for personalized medicine

Grant
314 employees
Biotechnology, Health Care
Rivaara Labs vs
Dhiti Omics
Dhiti Omics India

Precision Molecular Diagnostics & Genetic Testing

Seed
15 employees
Biotechnology, Health Care
Rivaara Labs vs
Cofactor Genomics
Cofactor Genomics United States

The Leaders in RNA

Venture round
11 employees
Biotechnology, Health Care
View all alternatives

FAQ About Rivaara Labs

Pioneering precision in diagnostics with timely, actionable solutions for better healthcare outcomes.
Rivaara Labs was founded in 2019.
Rivaara Labs operates in Biotechnology and Health Care. Its work centres on Precision Diagnostics, Molecular Diagnostics, Clinical Testing and Point of Care Solutions.
Rivaara Labs has approximately 51-200 employees.
Rivaara Labs has completed 1 funding round, raising a total of $600.00M. The latest funding stage is Private Equity.
Top alternatives and competitors to Rivaara Labs include Biocartis, Dhiti Omics, Cofactor Genomics, Molecular Testing Labs, GenePath Diagnostics. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Rivaara Labs and Biocartis are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Rivaara Labs, https://bouncewatch.com/company/rivaara-labs, updated 20 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes